GlassScriptPhysician profile
Marjorie Higgins Young
NPI 1851773352
$1,601.94
in general payments reported to CMS, 2019-2025
12 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.61 · 2022: $470 · 2023: $274 · 2024: $452 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $296.02 | 2022-2024 | |
| Novo Nordisk INC | $220.49 | 2022-2024 | Wegovy |
| Abbott Laboratories | $211.42 | 2023-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $151.19 | 2022 | |
| Xeris Pharmaceuticals, INC. | $134.97 | 2025 | Recorlev |
| Otsuka America Pharmaceutical, INC. | $122.96 | 2023-2024 | Rexulti |
| Axsome Therapeutics, INC. | $122.17 | 2024 | Auvelity |
| Inspire Medical Systems, INC. | $112.28 | 2023 | Inspire |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $99.60 | 2025 | |
| Gilead Sciences, INC. | $70.61 | 2021 | |
| Medtronic, INC. | $35.94 | 2023 | Synchromedii |
| Sanofi-Aventis U.S. LLC | $24.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.